Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
71.60
+4.88 (7.31%)
May 8, 2025, 4:00 PM EDT - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $5.14 billion as of May 8, 2025. Its market cap has increased by 24.42% in one year.
Market Cap
5.14B
Enterprise Value
4.07B
1-Year Change
24.42%
Ranking
Category
Stock Price
$71.60
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $5.14B, an increase of 545.84%. That is a compound annual growth rate of 63.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 4.78B | -14.11% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |